TP53INP1 inhibitors belong to a class of chemicals that specifically interact with the protein known as tumor protein p53-inducible nuclear protein 1 (TP53INP1). This protein is a stress-induced protein that plays a pivotal role in cellular processes such as cell cycle regulation and apoptosis. TP53INP1 is typically expressed at low levels in cells but can be upregulated in response to various stress signals, including DNA damage. The primary structure of TP53INP1 is characterized by the presence of several distinctive domains that are vital for its interaction with other cellular proteins, and the modulation of its function can have significant impacts on the cellular stress response mechanisms. Inhibitors targeting TP53INP1 are designed to bind to this protein and modulate its activity, typically aiming to alter its normal function within the cell.
The development of TP53INP1 inhibitors is rooted in the detailed understanding of the protein's three-dimensional structure and the biochemical pathways it influences. By interacting with TP53INP1, these inhibitors can affect the protein's ability to bind to other molecular partners or to participate in the regulation of gene expression. The design of these inhibitors often involves the use of sophisticated computational models to predict how small molecules might interact with specific regions of the TP53INP1 protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
Pifithrin-α(HBr) inhibits p53, potentially reducing TP53INP1 expression as TP53INP1 is a p53-inducible gene. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $197.00 $520.00 $1093.00 | 4 | |
Sunitinib, while primarily a tyrosine kinase inhibitor, may indirectly affect TP53INP1 expression through its impact on cellular stress pathways. | ||||||